tiprankstipranks
Advertisement
Advertisement
Genprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
PremiumThe FlyGenprex’s patent application for Reqorsa Gene Therapy accepted by IP Australia
2M ago
Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring
Premium
Company Announcements
Genprex Regains Nasdaq Compliance but Faces Ongoing Monitoring
3M ago
Genprex advances GPX-002 diabetes gene therapy program
Premium
Company Announcements
Genprex advances GPX-002 diabetes gene therapy program
3M ago
Genprex files to sell 1.28M shares of common stock for holders
PremiumThe FlyGenprex files to sell 1.28M shares of common stock for holders
5M ago
Genprex Expands Clinical Trials with New Site Addition
Premium
Company Announcements
Genprex Expands Clinical Trials with New Site Addition
5M ago
Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3
Premium
The Fly
Genprex adds Gabrail Cancer Center for Acclaim clinical trials 1 and 3
5M ago
Genprex Announces Securities Purchase Agreement and Offering
PremiumCompany AnnouncementsGenprex Announces Securities Purchase Agreement and Offering
6M ago
Genprex trading resumes
Premium
The Fly
Genprex trading resumes
6M ago
Genprex trading halted, volatility trading pause
Premium
The Fly
Genprex trading halted, volatility trading pause
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100